Product Program year 2025 Source: CMS Open Payments

Biofoam

Device Trauma & Extremities

PDI 00840420135643

Open in the dashboard

General payments

$166,653

846 payments

Research payments

$55,123

3 payments

Through program year 2025, $166,653 in general payments and $55,123 in research payments were reported against Biofoam (Trauma & Extremities).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

6 rows
Year Kind Amount Payments
2025 General $9,473 152
2024 General $12,726 196
2023 General $44,939 165
2022 General $27,820 199
2022 Research $55,123 3
2021 General $71,694 134

Breakdown

Who paid General payments · program years 2021–2025
  1. Stryker Corporation $166,653 846 payments
Top recipients General payments · program year 2025
  1. Michael Troiano Podiatrist, Foot & Ankle Surgery · Philadelphia, PA $2,000 21% · 1 payment
  2. Joseph Daniel Orthopaedic Surgery · Marlton, NJ $1,000 11% · 1 payment
  3. Lorraine Boakye Orthopaedic Surgery · Philadelphia, PA $277 3% · 2 payments
  4. Daniel Farber Orthopaedic Surgery · Allentown, PA $205 2% · 2 payments
  5. Mario Cala Podiatrist, Foot & Ankle Surgery · Hialeah, FL $174 2% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Podiatrist, Foot & Ankle Surgery Podiatrist $5,242 57% · 68 practitioners
  2. Orthopaedic Surgery $1,849 20% · 13 practitioners
  3. Podiatrist $1,197 13% · 30 practitioners
  4. Foot and Ankle Surgery Orthopaedic Surgery $462 5% · 8 practitioners
  5. Sports Medicine Orthopaedic Surgery $161 2% · 2 practitioners

The top 5 of 9 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Pennsylvania $3,478 37% · 19 recipients
  2. New Jersey $1,037 11% · 2 recipients
  3. New York $762 8% · 12 recipients
  4. Georgia $466 5% · 7 recipients
  5. Texas $392 4% · 10 recipients

The top 5 of 29 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

846 general · 3 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record